A single-institution phase II study indicated that combination chemotherapy using UFT (tegafur and uracil) plus cisplatin (Platinol) in patients with non-small-cell lung cancer was active with less host toxicity than other cisplatin-
Mutsuo Kuba, MD
Advertisement
Articles by Mutsuo Kuba, MD
Advertisement
Latest Updated Articles
- UFT Plus Cisplatin in Advanced Non-Small-Cell Lung Cancer: Interim Analysis of 67 Patients
Published: September 2nd 1997 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Ficerafusp Alfa/Pembrolizumab Receives FDA BTD in Front-Line HNSCC
2
64Cu-SAR-bisPSMA PET Detects More Prostate Cancer Lesions vs SOC
3
Comprehensive Cancer Database May Enhance Personalized Therapy
4
FDA Grants Fast Track Designation to NG-350A For pMMR Rectal Cancer
5
